Amicus Therapeutics Inc
NASDAQ:FOLD

Watchlist Manager
Amicus Therapeutics Inc Logo
Amicus Therapeutics Inc
NASDAQ:FOLD
Watchlist
Price: 10.55 USD 6.57% Market Closed
Market Cap: 3.3B USD

Intrinsic Value

The intrinsic value of one FOLD stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.55 USD, Amicus Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

FOLD Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Amicus Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

FOLD looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if FOLD is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about FOLD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is FOLD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Amicus Therapeutics Inc.

Explain Valuation
Compare FOLD to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about FOLD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amicus Therapeutics Inc

Current Assets 594.1m
Cash & Short-Term Investments 263.8m
Receivables 113.8m
Other Current Assets 216.4m
Non-Current Assets 274.7m
PP&E 49.3m
Intangibles 212.5m
Other Non-Current Assets 12.9m
Current Liabilities 198.9m
Accounts Payable 19.1m
Accrued Liabilities 179.8m
Non-Current Liabilities 439.5m
Long-Term Debt 392m
Other Non-Current Liabilities 47.5m
Efficiency

Free Cash Flow Analysis
Amicus Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amicus Therapeutics Inc

Revenue
598.7m USD
Cost of Revenue
-61.2m USD
Gross Profit
537.5m USD
Operating Expenses
-503m USD
Operating Income
34.5m USD
Other Expenses
-48.6m USD
Net Income
-14.1m USD
Fundamental Scores

FOLD Profitability Score
Profitability Due Diligence

Amicus Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Amicus Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

FOLD Solvency Score
Solvency Due Diligence

Amicus Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average D/E
hidden
Solvency
Score

Amicus Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FOLD Price Targets Summary
Amicus Therapeutics Inc

Wall Street analysts forecast FOLD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FOLD is 16.78 USD with a low forecast of 11.11 USD and a high forecast of 23.1 USD.

Lowest
Price Target
11.11 USD
5% Upside
Average
Price Target
16.78 USD
59% Upside
Highest
Price Target
23.1 USD
119% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Amicus Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for FOLD is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

FOLD Insider Trading
Buy and sell transactions by insiders

FOLD News

Other Videos
What is the Intrinsic Value of one FOLD stock?

The intrinsic value of one FOLD stock under the Base Case scenario is hidden USD.

Is FOLD stock undervalued or overvalued?

Compared to the current market price of 10.55 USD, Amicus Therapeutics Inc is hidden .

Back to Top